U.S. General Merchandise and Department Stores Stock News

EverCommerce Inc. (NasdaqGS:EVCM) was added in June 2026 to several Russell value benchmarks, including the Russell 2000, 2500, 3000, Small Cap Composite, and 3000E Value indices. This broad inclusion across multiple Russell value indices highlights how EverCommerce is now being grouped with value-oriented small and mid-cap peers in key benchmarks tracked by institutional investors. Next, we’ll examine how EverCommerce’s broad Russell value index inclusion may influence its investment...

Vera Therapeutics (VERA) is in focus after the US Food and Drug Administration granted accelerated approval for TRUTAKNA, the company’s first commercial product for adults with primary IgA nephropathy at risk for disease progression. See our latest analysis for Vera Therapeutics. The FDA approval of TRUTAKNA comes after a strong run for Vera Therapeutics, with the 1 year total shareholder return of 74.25% contrasting with a year to date share price return that is down 12.73% and shorter term...

In June 2026, AMN Healthcare Services scheduled an August 6 conference call to discuss its second-quarter 2026 results and third-quarter outlook, while also announcing new commercial and people leadership appointments and highlighting momentum in its Managed Services Program and AI-driven staffing tools. At the same time, investors have been weighing this operational progress against concerns about softening traveler demand, declining earnings per share, and a weaker return on invested...

In early July 2026, Figure Technology Solutions announced a private offering of US$600 million in senior notes, intended primarily to fund its planned acquisition of Kiavi, an AI-powered lending platform for residential real estate investors, with any remaining proceeds earmarked for general corporate purposes. The move to raise guaranteed senior debt while decoupling the notes’ completion from the Kiavi deal underscores Figure’s push to scale its lending marketplace and maintain financing...

Why the latest Azenta event matters for investors Azenta (AZTA) has just completed the previously announced sale of its B Medical Systems business to Thelema S.à r.l. This represents a portfolio shift that places more emphasis on its core life sciences operations. For investors, this completed transaction creates a fresh reference point to reassess how Azenta’s sample management and multiomics segments, which together generated US$596.5 million in revenue, compare with the company’s current...

With bond yields climbing and oil back above $80, investors are again being reminded how quickly macro shocks can hit portfolios. Consumer staples stocks, which sell everyday essentials across markets like the US, UK, Canada, Australia, and New Zealand, can sometimes offer a different risk profile to more cyclical areas when volatility picks up, although that is not guaranteed. This article focuses on our Defensive Consumer Staples screener, built around the latest US Iran tensions and...

In late June 2026, BOK Financial Corporation was removed from the Russell 1000 Dynamic Index, altering its presence in a widely followed benchmark. This index removal may influence how index-tracking funds and benchmark-conscious investors treat BOK Financial within diversified portfolios. We’ll now explore how the loss of Russell 1000 Dynamic Index inclusion could influence BOK Financial’s existing investment narrative and outlook. Invest in the nuclear renaissance through our list of 89...

Constellation Brands (STZ) has drawn fresh attention after first quarter results showed lower sales but higher net income and earnings per share, alongside continued buybacks, a quarterly dividend and new index inclusions. See our latest analysis for Constellation Brands. Despite the solid first quarter earnings beat and continued buybacks, Constellation Brands’ share price has fallen 20.1% over the past three months to US$130.34, and the 1 year total shareholder return has declined 20.8%...

Uranium Energy stock has delivered a very strong 364.0% return over the past 5 years, yet its current valuation checks and premium market multiples suggest the shares are no longer an obvious bargain. A roughly 5 year return of 364.0% points to a stock that has already priced in a lot of optimism about Uranium Energy's future cash generation. The push into U.S. in situ recovery production and a proposed uranium refining and conversion facility can support long term earnings potential, while...

Wave Life Sciences stock has had a tough start to 2026, with a sharp year to date decline set against valuation checks that point to a stock that still looks expensive on traditional measures. Year to date, Wave Life Sciences is down 60.9%, which means recent gains over the past week and month have not yet repaired the earlier damage. Recent progress on its US redomiciliation and RNA programs for obesity and alpha-1 antitrypsin deficiency can support higher growth expectations, but execution...

Ameresco stock has delivered a steep 59.5% decline over the past five years, yet current valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to a premium while earnings-based multiples suggest the shares could be on the cheap side. Over the past 5 years, Ameresco shares are down 59.5%, which sets a cautious backdrop for any argument that the current price already bakes in a recovery story. The prospect of tighter rules on foreign power inverters...

On June 30, 2026, Kingsoft Cloud Holdings Limited shareholders approved amendments to its Second Amended and Restated Memorandum and Articles of Association, adopting a Third Amended and Restated version while confirming its authorized share capital remained at US$40,000,000 with 40,000,000,000 authorized shares and 4,531,784,801 issued shares. Morgan Stanley has now begun covering Kingsoft Cloud with an Overweight rating, framing the Chinese AI cloud provider’s growth prospects through its...

ZTO Express (Cayman) (ZTO) is back in focus after Zacks raised its consensus estimate for the company’s current year earnings by 6.8% over the past two months, highlighting its income profile. See our latest analysis for ZTO Express (Cayman). At a share price of US$23.22, ZTO Express (Cayman) has posted an 8.20% year to date share price return and a 35.23% total shareholder return over the past year. The recent 30 day share price gain of 5.07% contrasts with a 90 day decline of 5.11%,...

Casella Waste Systems has appointed Damian Ribar as Executive Vice President and Chief Operating Officer, effective July 20, 2026, and promoted longtime legal leader Shelley Sayward to Executive Vice President and General Counsel, expanding its senior leadership bench. These moves bring in a seasoned operator with deep acquisition-integration experience while elevating a key internal leader who oversees legal, regulatory, and risk functions central to Casella’s expansion plans. We’ll now...

Insiders who acquired US$2.65m worth of The Metals Royalty Company Inc.'s ( NASDAQ:TMCR ) stock at an average price of...

First Watch Restaurant Group, Inc. ( NASDAQ:FWRG ), might not be a large cap stock, but it saw a significant share...

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% growth over the past year with earnings forecasted to grow by another 18% annually. In this environment, identifying stocks that are potentially undervalued compared to their intrinsic value can offer investors opportunities for growth that align with these optimistic market conditions.

The market remained flat over the last week, but has shown a robust 18% increase over the past year, with earnings projected to grow by the same percentage annually. In this environment, identifying growth companies with substantial insider ownership can be particularly appealing as it often signals confidence from those closest to the business.

In the last week, the market has stayed flat, though it is up 18% over the past year and earnings are forecast to grow by 18% annually. Penny stocks may be a throwback term, but the opportunities they represent are far from old news. These smaller or newer companies can offer growth potential at lower price points, especially when backed by strong financial health and solid fundamentals.

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by an impressive 18%, with earnings forecasted to grow annually at a similar rate. In this environment, dividend stocks that offer substantial yields can be appealing for investors seeking consistent income alongside potential capital appreciation.

The recent price decline of 11% in Bonk, Inc.'s ( NASDAQ:BNKK ) stock may have disappointed insiders who bought...

Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) value has fallen 12% in the last week, but insiders who sold US$220k worth...

Curbline Properties (CURB) recently completed a follow on equity offering, issuing 10,000,000 common shares for total proceeds of $308.5 million. This transaction reshapes its capital base and potential dilution profile. See our latest analysis for Curbline Properties. Since listing, Curbline Properties has seen solid momentum, with a year to date share price return of 31.86% and a 1 year total shareholder return of 40.88%. The recent follow on offering price of $30.85 sits close to the...

Encompass Health stock sits at a point where a solid 5 year return record meets a valuation setup that screens as attractively priced, with both intrinsic value estimates using a Discounted Cash Flow (DCF) approach and market multiples pointing to the shares trading below what the cash flows may justify. Over the past 5 years, Encompass Health has returned 83.0%, which puts recent short term swings into the context of a stock that has already rewarded patient holders. Investor interest tied...